AU466300B2 - Composition for the treatment of hyperlipoproteinaemia - Google Patents

Composition for the treatment of hyperlipoproteinaemia

Info

Publication number
AU466300B2
AU466300B2 AU49918/72A AU4991872A AU466300B2 AU 466300 B2 AU466300 B2 AU 466300B2 AU 49918/72 A AU49918/72 A AU 49918/72A AU 4991872 A AU4991872 A AU 4991872A AU 466300 B2 AU466300 B2 AU 466300B2
Authority
AU
Australia
Prior art keywords
hyperlipoproteinaemia
treatment
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU49918/72A
Other languages
English (en)
Other versions
AU4991872A (en
Inventor
DR. HERBERT NOWAK and DR. KLAUS IRMSCHER DR. ZDENEK SIMANK
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of AU4991872A publication Critical patent/AU4991872A/en
Application granted granted Critical
Publication of AU466300B2 publication Critical patent/AU466300B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU49918/72A 1971-12-11 1972-12-11 Composition for the treatment of hyperlipoproteinaemia Expired AU466300B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEDE821615 1971-12-11
DE2161588A DE2161588C3 (de) 1971-12-11 1971-12-11 Mittel zur Behandlung von Hyperlipoproteinämien

Publications (2)

Publication Number Publication Date
AU4991872A AU4991872A (en) 1974-06-13
AU466300B2 true AU466300B2 (en) 1975-10-23

Family

ID=5827712

Family Applications (1)

Application Number Title Priority Date Filing Date
AU49918/72A Expired AU466300B2 (en) 1971-12-11 1972-12-11 Composition for the treatment of hyperlipoproteinaemia

Country Status (14)

Country Link
AT (1) AT327373B (xx)
AU (1) AU466300B2 (xx)
BE (1) BE792421A (xx)
BR (1) BR7208624D0 (xx)
CA (1) CA989307A (xx)
DD (1) DD102583A5 (xx)
DE (1) DE2161588C3 (xx)
FR (1) FR2162493B1 (xx)
GB (1) GB1356094A (xx)
HU (1) HU167337B (xx)
IL (1) IL40912A (xx)
MY (1) MY7700129A (xx)
NL (1) NL159579B (xx)
ZA (1) ZA728251B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2502678C3 (de) * 1975-01-23 1981-05-14 Ludwig Merckle Kg Chem. Pharm. Fabrik, 7902 Blaubeuren Arzneimittel zur Behandlung primärer und sekundärer Hyperlipoproteinämien
DE2621873C3 (de) 1976-05-17 1981-05-07 Ludwig Merckle Kg Chem. Pharm. Fabrik, 7902 Blaubeuren Arzneimittel zur Behandlung von Hypercholesterinämien
FR2430229A1 (fr) * 1978-01-16 1980-02-01 Laruelle Claude Nouvelles compositions pour le traitement des hyperlipoproteinemies et procedes de preparation
US4820739A (en) * 1982-06-28 1989-04-11 Lucta, S.A. Fat suppressant
US4859703A (en) * 1987-06-15 1989-08-22 Warner-Lambert Company Lipid regulating compositions

Also Published As

Publication number Publication date
IL40912A0 (en) 1973-01-30
AU4991872A (en) 1974-06-13
ZA728251B (en) 1973-07-25
CA989307A (en) 1976-05-18
GB1356094A (en) 1974-06-12
NL159579B (nl) 1979-03-15
FR2162493B1 (xx) 1975-06-20
DE2161588A1 (de) 1973-06-20
NL7216788A (xx) 1973-06-13
DE2161588C3 (de) 1980-02-14
BR7208624D0 (pt) 1973-09-20
MY7700129A (en) 1977-12-31
ATA1049172A (de) 1975-04-15
DD102583A5 (xx) 1973-12-20
AT327373B (de) 1976-01-26
IL40912A (en) 1975-11-25
DE2161588B2 (de) 1976-05-26
BE792421A (fr) 1973-06-07
FR2162493A1 (xx) 1973-07-20
HU167337B (xx) 1975-09-27

Similar Documents

Publication Publication Date Title
CA983855A (en) Hygienic-cosmetic compositions
AU472873B2 (en) Zwitterion-containing compositions
AU463173B2 (en) Reodorant compositions
CA1014146A (en) Process for the preparation of desacetoxycephalosporins
AU465305B2 (en) Composition
AU4775572A (en) Therapeutic compositions
AU466300B2 (en) Composition for the treatment of hyperlipoproteinaemia
AU464986B2 (en) Process for the preparation of methylcobalamine
AU4295872A (en) Compositions
AU463836B2 (en) Composition for treatment of asthma
CA993135A (en) Reflex-reflecting compositions
AU465178B2 (en) Process for the preparation of dea-steroids
CA878463A (en) Therapeutic composition
AU448609B2 (en) Therapeutic composition
AU467539B2 (en) Therapeutic compositions
AU460514B2 (en) Composition
CA871029A (en) Leak-stopping composition
CA969471A (en) Anti-mating composition
CA863868A (en) Composition
CA887055A (en) Complex compounds of the cobalt-phthalocyanine series
CA872279A (en) N-arylnaphthylamine compositions
CA878025A (en) Aminopolymer compositions
AU482338B2 (en) Compositions for treating the hair
CA885466A (en) Process for the preparation of substituted 3-aminobenzothiophenes
AU464060B2 (en) N-isobornyloxycarbonylcephalosporin c